OTC : TRSBF

3SBio Inc.

$2.15 USD

$0 (0.0%)

Volume
1.5K
Average Volume
760
Market Capitalization
$5.38B
P/E Ratio
4.09
Dividend Yield
1.55%
Price Target
Year High
$4.74
Year Low
$2.00
Day High
—
Day Low
—
Payout Ratio
$0.06
Current Ratio
$5.13
Company Overview

OTC

Jing Lou

Biotechnology

Healthcare

TRSBF

6109

CN

USD

https://www.3sbio.com

86 24 2538 6000

G8875G102

N/A

Liquidity Metrics

0.10

5.13

4.90

2.79

0.06

Sales & Valuation

$17.24B

1.97

1.28

3.74

3.73

Profitability

$3.36

$8.26B

47.93%

60.74%

38.96%

23.39%

P/E Metrics

4.09

0.01

0.01

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Poll Results

About 3SBio Inc. (OTC:TRSBF) Stock

3SBio Inc. is a China-based investment holding company deeply engaged in the biopharmaceutical sector, encompassing the entire value chain from research and development to manufacturing, marketing, and sales of its innovative products. The company's extensive biopharmaceutical portfolio caters to a wide array of therapeutic needs. This includes treatments for various blood disorders like TPIAO (for chemotherapy-induced or immune thrombocytopenia), EPIAO and SEPO (recombinant erythropoietins for anemia), and SPARIN (a low-molecular-weight heparin for deep vein thrombosis prophylaxis and treatment, as well as for preventing clotting during hemodialysis), alongside Aiyishu for iron-deficiency anemia. Its autoimmune and inflammatory disease offerings feature YISAIPU, a tumor necrosis factor in ... hibitor effective against rheumatoid arthritis, ankylosing spondylitis, and psoriasis. In the oncology domain, 3SBio provides Cipterbin for HER2-positive metastatic breast cancer (in combination with chemotherapy), Intefen (a recombinant human interferon for lymphatic/hematopoietic malignancies and viral infections), and Inleusin (human interleukin-2 for renal cell carcinoma, melanoma, and thoracic fluid accumulation). Other specialized products address conditions such as male alopecia and alopecia areata (Mandi), acute rejection post-renal transplant (Xenopax), glycemic control in type 2 diabetes (Byetta), and diabetic retinopathy (Qiming Keli). In addition to its pharmaceutical operations, 3SBio diversifies its activities through services encompassing trading, project management, consulting, technology, and agriculture. The company has forged strategic collaboration agreements with a multitude of international partners, including prominent names like AstraZeneca, Lilly, Toray Industries Inc, Samsung Bioepis, Refuge Biotechnologies, Verseau, TLC, Numab, GenSight, Sensorion, and the Dana-Farber Cancer Institute. Established in 1993, the company maintains its headquarters in Shenyang, China.

Frequently Asked Questions

What is the current 3SBio Inc. (TRSBF) stock price?

3SBio Inc.(OTC:TRSBF) stock price is $2.15 in the last trading session. During the trading session, TRSBF stock reached the peak price of $4.74 while $2 was the lowest point it dropped to. The percentage change in TRSBF stock occurred in the recent session was 0.0% while the dollar amount for the price change in TRSBF stock was $0.

TRSBF's industry and sector of operation?

The OTC listed TRSBF is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of TRSBF?

Dongmei Su | Senior Vice President & Executive Director
Jing Lou | Co-Founder, Executive Chairman, Chief Executive Officer & President
Yong Xu | General Manager of Shenzhen Sciprogen Bio-pharmaceutical Technology Co., Ltd.
An Yu | General Manager of Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd.
Xiang He | Chief Financial Officer

How many employees does TRSBF have?

Number of TRSBF employees currently stands at 6109. TRSBF operates from No. 3 A1, Road 10, Shenyang, LI 110027, CN.

Link for TRSBF official website?

Official Website of TRSBF is: https://www.3sbio.com

How do I contact TRSBF?

TRSBF could be contacted at phone #86 24 2538 6000 and can also be accessed through its website. TRSBF operates from No. 3 A1, Road 10, Shenyang, LI 110027, CN.

How many shares of TRSBF are traded daily?

The average number of TRSBF shares traded daily for last 3 months was 760.

What is the market cap of TRSBF currently?

The market value of TRSBF currently stands at $5.38B with its latest stock price at $2.15